Skip to main content
. 2021 Jul 12;23:92. doi: 10.1186/s12968-021-00775-8

Fig. 1.

Fig. 1

Representative cases of a healthy subject (A) and of left ventricular (LV) hypertrophy (LVH) in an athlete (B) and in patients with hypertensive heart disease (HHD) (C), hypertrophic cardiomyopathy (HCM) (D) and cardiac amyloidosis (E), respectively